This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Lecithin, soybean
- DrugBank Accession Number
- DB14161
- Background
A complex mixture of phospholipids; glycolipids; and triglycerides; with substantial amounts of phosphatidylcholines; phosphatidylethanolamines; and phosphatidylinositols, which are sometimes loosely termed as 1,2-diacyl-3-phosphocholines. Lecithin is a component of the cell membrane and commercially extracted from soybeans and egg yolk. The emulsifying and surfactant properties are useful in food additives and for forming organogels (gels).
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- Lecithin, soy
- Lecithins, from soy beans
- Lecithins, soya
- Soy lecithin
- Soy lecithin,hydroxylated
- Soy lecithins
- Soya lecithins
- Soybean lecithins
- Soybean phospholipids
- External IDs
- E-322(I)
- INS NO.322(I)
- INS-322(I)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Acne Combination Product in combination with: Levocarnitine (DB00583), Ubidecarenone (DB09270) ••• ••• •••••• Used in combination to treat Bmi >30 kg/m2 Combination Product in combination with: Levocarnitine (DB00583) ••• ••• ••••••• Used in combination to treat Bulimia nervosa Combination Product in combination with: Levocarnitine (DB00583) ••• ••• ••••••• Used in combination to manage Weight Combination Product in combination with: Levocarnitine (DB00583) ••• ••• ••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Essentiale Forte N Capsule 300 mg Oral DKSH MALAYSIA SDN BHD 2020-09-08 Not applicable Malaysia 
Essentiale MAX 600mg Capsule Capsule 600 mg Oral SANOFI-AVENTIS (MALAYSIA) SDN. BHD. 2020-09-08 2021-12-12 Malaysia Lipopharm® Capsule 300mg Capsule 300 mg Oral IMEKS PHARMA SDN. BHD. 2020-09-08 Not applicable Malaysia SOROCI NMF Serum Cream 0.06 g/30mL Topical Onsaemiro Co.,Ltd. 2017-12-01 2018-07-01 US 
เอสเซนเชียล 600 มก. Capsule 600 mg Oral บริษัท ซาโนฟี่-อเวนตีส (ประเทศไทย) จำกัด 2016-11-20 Not applicable Thailand 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image BEAUTIFUL CONTRACT - Slimming contract -Hui Ju Sheng Enterprise Corporation Ltd. Lecithin, soybean (36 mg/600mg) + Levocarnitine (210 mg/600mg) Capsule, gelatin coated Oral Phytopia Co., Ltd. 2016-04-01 2017-02-01 US GNC PP AA Formula Lecithin, soybean (15 mg) + Casein (1 g) + Vitamin E (1 IU) Capsule Oral ONI Global (Malaysia) Sdn Bhd 2020-09-08 Not applicable Malaysia IQQU Acne Serum Lecithin, soybean (0.024 g/30g) + Levocarnitine (0.012 g/1g) + Ubidecarenone (0.0012 g/1g) Lotion Topical Iqqu Usa Co. 2009-08-01 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image BEAUTIFUL CONTRACT - Slimming contract -Hui Ju Sheng Enterprise Corporation Ltd. Lecithin, soybean (36 mg/600mg) + Levocarnitine (210 mg/600mg) Capsule, gelatin coated Oral Phytopia Co., Ltd. 2016-04-01 2017-02-01 US IQQU Acne Serum Lecithin, soybean (0.024 g/30g) + Levocarnitine (0.012 g/1g) + Ubidecarenone (0.0012 g/1g) Lotion Topical Iqqu Usa Co. 2009-08-01 Not applicable US SOROCI NMF Serum Lecithin, soybean (0.06 g/30mL) Cream Topical Onsaemiro Co.,Ltd. 2017-12-01 2018-07-01 US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 1DI56QDM62
- CAS number
- 8030-76-0
References
- General References
- Not Available
- External Links
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule, gelatin coated Oral Capsule Oral 300 mg Lotion Topical Capsule Oral Capsule Oral Tablet Oral Cream Topical 0.06 g/30mL Capsule Oral 1200 mg Capsule Oral 600 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 29, 2018 16:35 / Updated at June 12, 2020 16:53